Evidence map›Paper›PMID 36653345›Full record

ArticleCell death & disease2023

SIRT6 is a key regulator of mitochondrial function in the brain.

Dmitrii Smirnov, Ekaterina Eremenko, Daniel Stein, Shai Kaluski, Weronika Jasinska, Claudia Cosentino, Barbara Martinez-Pastor, Yariv Brotman, Raul Mostoslavsky, Ekaterina Khrameeva and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Dmitrii SmirnovDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel.
Ekaterina EremenkoDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel.
Daniel SteinDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel.
Shai KaluskiDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel.
Weronika JasinskaDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel.
Claudia CosentinoThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA.
Barbara Martinez-PastorThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA.
Yariv BrotmanDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel.
Raul MostoslavskyThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA.ORCID 0000-0002-7740-5212
Ekaterina KhrameevaCenter for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, Moscow, 121205, Russia. e.khrameeva@skoltech.ru.
Debra ToiberDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, 8410501, Israel. toiber@bgu.ac.il.ORCID 0000-0002-1465-0130
Ben-Gurion University of the Negev · ILHarvard University · USBroad Institute · USSkolkovo Institute of Science and Technology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SIRT6 deacetylase has been implicated in DNA repair, telomere maintenance, glucose and lipid metabolism and, importantly, it has critical roles in the brain ranging from its development to neurodegeneration. Here, we combined transcriptomics and metabolomics approaches to characterize the functions of SIRT6 in mouse brains. Our analysis reveals that SIRT6 is a central regulator of mitochondrial activity in the brain. SIRT6 deficiency in the brain leads to mitochondrial deficiency with a global downregulation of mitochondria-related genes and pronounced changes in metabolite content. We suggest that SIRT6 affects mitochondrial functions through its interaction with the transcription factor YY1 that, together, regulate mitochondrial gene expression. Moreover, SIRT6 target genes include SIRT3 and SIRT4, which are significantly downregulated in SIRT6-deficient brains. Our results demonstrate that the lack of SIRT6 leads to decreased mitochondrial gene expression and metabolomic changes of TCA cycle byproducts, including increased ROS production, reduced mitochondrial number, and impaired membrane potential that can be partially rescued by restoring SIRT3 and SIRT4 levels. Importantly, the changes we observed in SIRT6-deficient brains are also occurring in aging human brains and particularly in patients with Alzheimer's, Parkinson's, Huntington's, and Amyotrophic lateral sclerosis disease. Overall, our results suggest that the reduced levels of SIRT6 in the aging brain and neurodegeneration initiate mitochondrial dysfunction by altering gene expression, ROS production, and mitochondrial decay.

Indexed as

SirtuinsAgingAnimalsBrainDNA, MitochondrialHumansMiceMitochondriaReactive Oxygen SpeciesDNA, MitochondrialReactive Oxygen SpeciesSIRT6 protein, humanSirt6 protein, mouseSirtuins

Identifiers

PMID36653345
PMCPMC9849342
OpenAlexW4317396521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.